Provided by Tiger Trade Technology Pte. Ltd.

Arbutus Biopharma

5.06
-0.0750-1.46%
Volume:2.07M
Turnover:10.48M
Market Cap:995.53M
PE:6.40
High:5.14
Open:5.11
Low:5.04
Close:5.13
52wk High:5.45
52wk Low:3.50
Shares:196.94M
Float Shares:123.00M
Volume Ratio:0.74
T/O Rate:1.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7896
EPS(LYR):-0.1748
ROE:89.58%
ROA:48.84%
PB:3.85
PE(LYR):-28.91

Loading ...

Jun 05, 2024

Major Issues Report

Form 8-K - Current report
May 28, 2024

Major Issues Report

Form 8-K - Current report
May 22, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 09, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
May 02, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2024

Major Issues Report

Form 8-K - Current report
May 02, 2024

Major Issues Report

Form 8-K - Current report
Apr 04, 2024

Major Issues Report

Form 8-K - Current report
Mar 05, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 29, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 04, 2024

Major Issues Report

Form 8-K - Current report
Nov 21, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 10, 2023

Major Issues Report

Form 8-K - Current report
Nov 07, 2023

Major Issues Report

Form 8-K - Current report
Nov 07, 2023

Major Issues Report

Form 8-K - Current report
Nov 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]